Abdel A. Mohamed

Array ( [id] => 3118083 [patent_doc_number] => 05380710 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-01-10 [patent_title] => 'Pharmaceutical compositions containing ACTH (1-24) for the therapy of shock conditions and respiratory and cardiocirculatory insufficiences' [patent_app_type] => 1 [patent_app_number] => 7/596564 [patent_app_country] => US [patent_app_date] => 1990-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 8 [patent_no_of_words] => 2782 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/380/05380710.pdf [firstpage_image] =>[orig_patent_app_number] => 596564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2922187 [patent_doc_number] => 05235043 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-08-10 [patent_title] => 'Production of biologically active, recombinant members of the NGF/BDNF family of neurotrophic proteins' [patent_app_type] => 1 [patent_app_number] => 7/594126 [patent_app_country] => US [patent_app_date] => 1990-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 18693 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/235/05235043.pdf [firstpage_image] =>[orig_patent_app_number] => 594126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2930762 [patent_doc_number] => 05188942 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-02-23 [patent_title] => 'Method for determining bluetongue virus antibodies in serum' [patent_app_type] => 1 [patent_app_number] => 7/594071 [patent_app_country] => US [patent_app_date] => 1990-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5934 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/188/05188942.pdf [firstpage_image] =>[orig_patent_app_number] => 594071 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2925911 [patent_doc_number] => 05187070 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-02-16 [patent_title] => 'Assay for motile facultative anaerobic pathogens' [patent_app_type] => 1 [patent_app_number] => 7/594647 [patent_app_country] => US [patent_app_date] => 1990-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 3715 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/187/05187070.pdf [firstpage_image] =>[orig_patent_app_number] => 594647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2889101 [patent_doc_number] => 05176909 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-01-05 [patent_title] => 'Stable immunogen composition for oral administration' [patent_app_type] => 1 [patent_app_number] => 7/590230 [patent_app_country] => US [patent_app_date] => 1990-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 2985 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/176/05176909.pdf [firstpage_image] =>[orig_patent_app_number] => 590230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2800725 [patent_doc_number] => 05114712 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-05-19 [patent_title] => 'Common antigen (PSC-A) to Pseudomonas aeruginosa which acts as an agent for protecting Pseudomonas aeruginosa infection' [patent_app_type] => 1 [patent_app_number] => 7/586337 [patent_app_country] => US [patent_app_date] => 1990-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6978 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/114/05114712.pdf [firstpage_image] =>[orig_patent_app_number] => 586337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2902471 [patent_doc_number] => 05218094 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-06-08 [patent_title] => 'Neuronotrophic factor derived from mammalian brain tissue' [patent_app_type] => 1 [patent_app_number] => 7/562024 [patent_app_country] => US [patent_app_date] => 1990-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 9802 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/218/05218094.pdf [firstpage_image] =>[orig_patent_app_number] => 562024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2677552 [patent_doc_number] => 05066492 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-11-19 [patent_title] => 'Method of treating herpes simplex virus' [patent_app_type] => 1 [patent_app_number] => 7/528344 [patent_app_country] => US [patent_app_date] => 1990-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1220 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/066/05066492.pdf [firstpage_image] =>[orig_patent_app_number] => 528344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2926132 [patent_doc_number] => 05232694 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-08-03 [patent_title] => 'Canine corona virus vaccine' [patent_app_type] => 1 [patent_app_number] => 7/514069 [patent_app_country] => US [patent_app_date] => 1990-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2371 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/232/05232694.pdf [firstpage_image] =>[orig_patent_app_number] => 514069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2859280 [patent_doc_number] => 05166320 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-11-24 [patent_title] => 'Carrier system and method for the introduction of genes into mammalian cells' [patent_app_type] => 1 [patent_app_number] => 7/504064 [patent_app_country] => US [patent_app_date] => 1990-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 5670 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/166/05166320.pdf [firstpage_image] =>[orig_patent_app_number] => 504064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2926067 [patent_doc_number] => 05219567 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-06-15 [patent_title] => 'Vaccine against herpes viruses' [patent_app_type] => 1 [patent_app_number] => 7/495710 [patent_app_country] => US [patent_app_date] => 1990-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 10212 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/219/05219567.pdf [firstpage_image] =>[orig_patent_app_number] => 495710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2842145 [patent_doc_number] => 05106619 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-04-21 [patent_title] => 'Preparation of inactivated viral vaccines' [patent_app_type] => 1 [patent_app_number] => 7/463081 [patent_app_country] => US [patent_app_date] => 1990-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11519 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/106/05106619.pdf [firstpage_image] =>[orig_patent_app_number] => 463081 [rel_patent_id] =>[rel_patent_doc_number] =>)